The Food and Drug Administration has issued a worrisome new warning about Lamictal, a drug used to treat seizures in children and bipolar disorder in adults. According to the FDA,…
Read More
As a defective medication lawyer, I was interested to read that the U.S. Food and Drug Administration will convene an expert advisory panel in September to determine whether to allow…
Read More
I’ve written here before as a pharmaceutical liability lawyer about the frightening side effects of the drug Fosamax (alendronate sodium). Fosamax is intended to treat osteoarthritis, but among its side…
Read More
Recently I wrote about Dr. Frances Oldham Kelsey, whose leadership helped the FDA establish scientific standards that drug companies had to meet before they could market their drugs in the…
Read More
According to the Associated Press, FDA officials have issued a warning that popular bisphosphonates drugs that treat osteoporosis may actually increase the risk to thigh fractures. Patients taking bone-strengthening drugs…
Read More
The FDA has finally decided what to do about the serious heart risks to patients taking the diabetes drug Avandia (rosiglitazone). Given the increased danger of heart attack, stroke, and…
Read More
As a dangerous prescription medication lawyer, I often see reports of drug makers seeking the U.S. Food and Drug Administration's approval to sell their medications for different illnesses than the…
Read More
On January 23, 2013, a Case Management Order stated that a status conference will be held on March 21, 2013, for the transvaginal mesh MDL that is currently underway in…
Read More
Doctors and patients are worried about whether the diabetes drug Avandia (rosiglitazone) is safe, as I've discussed on several occasions this year from my perspective as a dangerous prescription medication…
Read More
Brainsway Ltd is hoping to reach an agreement with a medical device company in order to gain help in marketing its new non-invasive Deep TMS system that is used for…
Read More